Prevalence of Anti-Insulin, Anti-IA2, Anti-GAD, Anti-IR Auto-antibodies and Anti-Neu5Gc Antibodies in Diabetic Type I And II Patients
Ganou, Christina-Julia/ Petrou, Christos/ Zografou, Ioanna/ Kotsa, Kalliopi/ Varsamidou, Efterpi/ Sampanis, Christos/ Giovos, Ioannis/ Oulorgia, Jensila/ Damontsidou, Katerina/ Eleftheriou, Phaedra/ Zaimi, Terpsithea/ Varsamidis, Konstantinos/ Markou, Helen-Irene/ Γκάνου, Χριστίνα-Τζούλια/ Δαμοντσίδου, Κατερίνα/ Ελευθερίου, Φαίδρα/ Βαρσαμίδης, Κωνσταντίνος/ Μάρκου, Ελένη-Ειρήνη/ Ζαΐμη, Tερψιθέα/ Βαρσαμίδου, Ευτέρπη/ Σαμπάνης, Χρήστος/ Ζωγράφου, Ιωάννα/ Κότσα, Καλλιόπη/ Γιώβος, Ιωάννης/ Πέτρου, Χρήστος
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ganou, Christina-Julia | el |
dc.contributor.author | Petrou, Christos | el |
dc.contributor.author | Zografou, Ioanna | el |
dc.contributor.author | Kotsa, Kalliopi | el |
dc.contributor.author | Varsamidou, Efterpi | el |
dc.contributor.author | Sampanis, Christos | el |
dc.contributor.author | Giovos, Ioannis | el |
dc.contributor.author | Oulorgia, Jensila | el |
dc.contributor.author | Damontsidou, Katerina | el |
dc.contributor.author | Eleftheriou, Phaedra | el |
dc.contributor.author | Zaimi, Terpsithea | el |
dc.contributor.author | Varsamidis, Konstantinos | el |
dc.contributor.author | Markou, Helen-Irene | el |
dc.contributor.other | Γκάνου, Χριστίνα-Τζούλια | el |
dc.contributor.other | Δαμοντσίδου, Κατερίνα | el |
dc.contributor.other | Ελευθερίου, Φαίδρα | el |
dc.contributor.other | Βαρσαμίδης, Κωνσταντίνος | el |
dc.contributor.other | Μάρκου, Ελένη-Ειρήνη | el |
dc.contributor.other | Ζαΐμη, Tερψιθέα | el |
dc.contributor.other | Βαρσαμίδου, Ευτέρπη | el |
dc.contributor.other | Σαμπάνης, Χρήστος | el |
dc.contributor.other | Ζωγράφου, Ιωάννα | el |
dc.contributor.other | Κότσα, Καλλιόπη | el |
dc.contributor.other | Γιώβος, Ιωάννης | el |
dc.contributor.other | Πέτρου, Χρήστος | el |
dc.date.accessioned | 2015-07-12T15:43:22Z | el |
dc.date.accessioned | 2018-02-28T13:48:50Z | - |
dc.date.available | 2015-07-12T15:43:22Z | el |
dc.date.available | 2018-02-28T13:48:50Z | - |
dc.date.issued | 2013 | el |
dc.identifier.citation | Varsamidis, K.,Phaerdra,Eleftheriou.,Zaimi,Terpsithea.,Markou,Helen-Irene.,Damontsidou,Ekaterini.,Oulorgia,Jensila.,Varsamidou,Efterpi.,Sampanis,Christos.,Zografou,Ioanna.,Kotsa,Kalliopi.,Giovos,Ioannis.,Petrou,Christos.,Ganou,Christina-Joulia.(2013). Prevalence of Anti-Insulin, Anti-IA2, Anti-GAD, Anti-IR Auto-antibodies and Anti-Neu5Gc Antibodies in Diabetic Type I And II Patients.. Πρακτικά συνεδρίου από 4ο Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference "Technical Advances and Current Practices" που διεξήχθη σε Athens. Φορέας διεξαγωγής Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference. Athens: Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference. | el |
dc.identifier.citation | Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference, Athens, 2013 | el |
dc.identifier.uri | http://195.251.240.227/jspui/handle/123456789/8539 | - |
dc.description | Δημοσιεύσεις μελών--ΣΕΥΠ--Τμήμα Φυσικοθεραπείας, 2013 | el |
dc.description.abstract | Autoimmunity is a major cause of Diabetes, mainly IDDM. Although, inheritance is recognized, the etiology of the disease is not fully underst ood and environmental factors are believed to be involved. Background : A number of auto - antibodies are developed in diabetes type IA but also in diabetes type II. Since, antibodies are identified before the onset of disease; their measurement has been prop osed as a prognostic tool. Neu5Gc is a sialic acid synthesized by animals but not humans and birds. It can be incorporated in human cells and can trigger immune response. High concentrations of anti - Neu5Gc were detected by our team in diabetic patients, p roposing it as a probable environmental factor. = Objective : Anti - Insulin/anti - IA2/anti - GAD/anti - IR auto - antibodies and anti - Neu5GcIgG/IgM/IgA antibodies were measured in 40 type I and 50 type II patients. A probable correlation between the development of anti - Neu5Gc antibodies and auto - antibodies is investigated and their prognostic value is discussed. Results and Discussion : IgG/IgM/IgA auto - antibodies as well as anti - Neu5Gc antibodies were present in 50% of Diabetic type I patients. 88.9% of auto - antibod y positive samples were also anti - Neu5Gc positive and 90.9% of auto - antibody negative were also anti - Neu5Gc negative. Anti - insulin/anti - IA2/anti - GAD/anti - IR IgG/IgM/IgA were present in 13.8% of Diabetic type II patients, 83% of which were also anti - Neu5Gc positive. Conclusion : The results indicate a correlation between development of auto - antibodies and anti - Neu5Gc and introduce anti - Neu5Gc as a probable prognostic factor of diabetes type I | el |
dc.language.iso | en | el |
dc.relation.ispartof | Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference | el |
dc.rights | This item is probably protected by Copyright Legislation | el |
dc.rights | Το τεκμήριο πιθανώς υπόκειται σε σχετική με τα πνευματικά δικαιώματα νομοθεσία | el |
dc.subject | Anti-Insulin | el |
dc.subject | Diabetic type | el |
dc.subject | Patients | el |
dc.subject | Antibodies | el |
dc.title | Prevalence of Anti-Insulin, Anti-IA2, Anti-GAD, Anti-IR Auto-antibodies and Anti-Neu5Gc Antibodies in Diabetic Type I And II Patients | el |
dc.type | Conference article | el |
heal.type | other | el |
heal.type.en | Other | en |
heal.dateAvailable | 2018-02-28T13:49:50Z | - |
heal.language | el | el |
heal.access | free | el |
heal.recordProvider | ΤΕΙ Θεσσαλονίκης | el |
heal.fullTextAvailability | false | el |
heal.type.el | Άλλο | el |
Appears in Collections: | Δημοσιεύσεις σε Συνέδρια |
Files in This Item:
There are no files associated with this item.
Please use this identifier to cite or link to this item:
This item is a favorite for 0 people.
http://195.251.240.227/jspui/handle/123456789/8539
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.